Tag Archives: inflammatory bowel disease

New formula

In my post Reading Labels, I shared the notification label from our bag of Purina Pro Plan Gastrointestinal dog food. The food we have relied on for over two years is changing!

The reply from Purina says: “Ensuring the safety and quality of our pet food remains our top priority. While the product is now manufactured in Thailand instead of Europe, the benefits of this diet remain unchanged. With a new manufacturing location, there will be new sourcing for raw ingredients and slight recipe variations. Please be assured the new formula continues to deliver the same efficacy and benefits. We recommend a gradual transition to the new formula to support digestive tolerance. If you have concerns, please consult your vet for tailored advice.

Let’s compare ingredients…

ORIGINAL FORMULA

Rice, Corn, Pea protein, dried poultry protein, dried beet pulp, digest, soya protein, coconut oil, minerals, pork fat, monoglycerides, soya oil, fish oil; with nutritional additives Vit A, Vit D3, Vit E, Iron (II) sulphate monohydrate, calcium iodate anhydrous, copper (11) sulphate pentahydrate, manganese sulfphate monohydrate, zinc sulphate monohydrate, sodium selenite, antioxidants

NEW FORMULA

Brewers rice, whole grain corn, chicken meal, corn protein, chicken digest, minerals, vitamins, amino acids (Including calcium, phosphorus, sodium, chloride, potassium, magnesium, zinc, iron, manganese, copper, selenium, iodine, vitamin A, vitamin B1, vitamin B2, pantothenic acid, biotin, vitamin B6, vitamin B12, niacin, folic acid, vitamin C, vitamin D, vitamin E, choline, L-lysine, L-threonine, L-tryptophan) poultry oil, botanical oil (1%) (source of MCT) fish oil, glyceryl monosterate, prebiotic fibre (0.5%) (source of inulin) colostrum

I will follow my own advice to clients and transition to this food over a minimum of 10 days (and I’m planning longer than that). As a pet parent, however, I’m holding my breath that this new formula doesn’t upset Sox’s inflammatory bowel disease. Time will tell.

Kathleen Crisley is Fear-Free certified dog massage therapist and canine fitness trainer. She has a particular passion for working with dogs and their families to ensure injury prevention and quality of life. She specialises in working with anxious and emotionally damaged dogs. Her mobile practice, The Balanced Dog, is based in Christchurch, New Zealand

Vitamin B12 (cobalamin) supplementation – good news for IBD dogs

Dogs with inflammatory bowel disease (technical name, chronic enteropathy) often exhibit a deficiency in Vitamin B12. The treatment for this has typically been parenteral (injections) of cobalamin. These injections are painful and I can speak from personal experience with my greyhound, Sox, that subjecting the dog to painful injections is a good way of making them fearful of vet visits. So, it is nice to see that there has been a study about whether oral supplementation can be just as effective as the injectable form. (Spoiler alert: it is)

IBD can often be a challenging condition to manage: finding foods that the dog tolerates and managing other stressors can be easier said than done. Every dog is different, so what works for one may not for another. If you are located in New Zealand, I have started a Canine IBD support group. We originally met in video calls but I have now placed the group on Facebook. This group discusses products and services that you can access in NZ; many online support groups mention products that are not available here.

Kathleen Crisley is Fear-Free certified dog massage therapist and canine fitness trainer. She has a particular passion for working with dogs and their families to ensure injury prevention and quality of life. She specialises in working with anxious and emotionally damaged dogs. Her mobile practice, The Balanced Dog, is based in Christchurch, New Zealand


The Research …

Cobalamin (ie, vitamin B12) is an important intracellular cofactor. Hypocobalaminemia can result in cellular cobalamin deficiency that leads to increased methylmalonic acid (MMA) concentrations, is identified in 19% to 38% of dogs with chronic enteropathy (CE), and warrants cobalamin supplementation.1-3 Parenteral administration of cyanocobalamin has been the main method of supplementation; however, recent studies have shown similar efficacy of oral and parenteral supplementation for achieving normal serum cobalamin and/or MMA concentrations.4-6

This prospective studya was designed to evaluate tolerance and efficacy of oral versus parenteral cyanocobalamin supplementation for normalizing serum cobalamin concentrations in client-owned hypocobalaminemic (<250 pg/mL; reference interval, 240-590 pg/mL) dogs with clinical signs of CE, including subgroups of dogs with protein-losing enteropathy, severe CE (based on canine inflammatory bowel disease activity index [CIBDAI] scores >9), or moderate to severe hypocobalaminemia (<200 pg/mL). Dogs (n = 37) at 3 referral centers were randomly assigned to receive oral (capsules every 24 hours for 12 weeks) or parenteral (SC injections weekly for 6 weeks with 1 additional injection 4 weeks later) cobalamin. Serum cobalamin and CIBDAI scores were assessed at inclusion, week 7, and week 13. Serum MMA concentration was measured at inclusion and week 13. Owners completed a questionnaire on treatment adherence, palatability (oral supplementation group only), tolerance, and satisfaction at week 13.

Nineteen dogs (11/18 in the oral treatment group and 8/19 in the parenteral treatment group) completed the study. All dogs in the oral treatment group and 7 dogs in the parenteral treatment group had normalized or increased serum cobalamin concentrations at weeks 7 and 13. No significant difference in serum cobalamin concentration between treatment groups was identified at week 13, regardless of presence of protein-losing enteropathy, severity of hypocobalaminemia, and CIBDAI score at inclusion. In addition, no significant differences in serum MMA concentrations, treatment adherence, satisfaction, or tolerance scores were identified between treatment groups at week 13.

… The Takeaways

Key pearls to put into practice:

  • Hypocobalaminemia is often identified in dogs with CE. Measuring serum cobalamin concentration is an important diagnostic step in dogs with chronic clinical signs of GI disease.
  • Oral cyanocobalamin supplementation is well tolerated and effective for normalizing serum cobalamin concentrations in most dogs with hypocobalaminemia secondary to CE—regardless of clinical disease status or severity of hypocobalaminemia (including serum cobalamin concentrations below the lower limit of the reference interval)—and can be considered as a treatment option.
  • Re-evaluation of serum cobalamin concentration is recommended 4 weeks after supplementation is completed because some dogs may not respond to oral or parenteral cobalamin.

a This study was partially funded by ADM Protexin.

Journal reference: Dor C, Nixon S, Schmitz SS, et al. Efficacy and tolerance of oral versus parenteral cyanocobalamin supplement in hypocobalaminaemic dogs with chronic enteropathy: a controlled randomised open-label trial. J Small Anim Pract. 2024;65(5):317-328. doi:10.1111/jsap.13705

Source: Clinician’s Brief

Fasting together

This is Sox on Tuesday morning. He was scheduled to go to the vet for a fasting blood test and could not have his breakfast. I didn’t think it was fair to eat breakfast when he couldn’t and so we fasted together.

I couldn’t bear the thought of him being hungry watching me eat as normal. He would have thought something was wrong, or he was being punished or teased. Dogs are sentient, capable of feelings and sensation. Feeling hungry and left out are reasonable assumptions in this situation.

Do you fast in sympathy with your dog?

My Sox is well on his way to a confirmed diagnosis of Inflammatory Bowel Disease; a condition we cannot cure but can only find a way to manage. It’s tough when he is not yet 5 years old with a lifetime ahead of him. I was told that Sox would regularly collapse after racing with a condition called acidosis. But I also wonder if he wasn’t already showing the symptoms of IBD (with regular bouts of inappetence and diarrhea) which would have zapped his energy stores.

We will persevere and I will update everyone about Sox’s progress in future posts.

Kathleen Crisley, Fear-Free certified professional and specialist in dog massage, rehabilitation and nutrition/food therapy, The Balanced Dog, Christchurch, New Zealand

Growing up with a dog might protect against Crohn’s disease

A recent study suggests that having a pet dog or a larger family in early life may protect against Crohn’s disease, a type of inflammatory bowel disease.

Researchers observed that individuals who owned a dog as a child were less likely in later life to have increased gut permeability, which is an early indicator of Crohn’s disease.

These results may help understand how environmental factors, such as having a pet dog, may influence the risk of Crohn’s disease.

Having a dog as a pet in childhood may be protective against Crohn’s disease, a study suggests. Catherine Falls Commercial/Getty Image

Owning a dog or growing up in a large family during childhood could reduce the risk of Crohn’s disease later in life, according to a study presented at the Digestive Disease Week conference in San Diego.

The study also reports that owning a dog and having a larger family size were associated with changes in gut microbiome composition or gut permeability, paving the way to understand how these factors could influence the risk of Crohn’s disease.

The study’s co-author Dr. Williams Turpin, a research associate at Mount Sinai Hospital, told Medical News Today, “[ these results] imply that environmental factors are associated with risk of developing Crohn’s disease, and thus offer novel modifiable targets for studies aiming to reduce the risk of developing Crohn’s disease.”

Source: Medical News Today

Dog Poop Microbiome Predicts Canine Inflammatory Bowel Disease

Our gut microbiomes — the varieties of microbes living in our digestive tracts — may play a role in inflammatory bowel disease (IBD). Since dogs can also suffer from IBD, researchers at University of California San Diego School of Medicine analyzed fecal samples from dogs with and without the disease. They discovered a pattern of microbes indicative of IBD in dogs. With more than 90 percent accuracy, the team was able to use that information to predict which dogs had IBD and which did not. However, they also determined that the gut microbiomes of dogs and humans are not similar enough to use dogs as animal models for humans with this disease.

The study is published October 3, 2016 in Nature Microbiology.

jorgie
This French Bulldog, named Jorgie, has recently been diagnosed with IBD. A test based on this research would likely be more cost effective for diagnosis and lead to earlier detection. Photo: K Crisley, The Balanced Dog

“One of the really frustrating things about IBD in humans is that it’s hard to diagnose — it usually requires intestinal biopsies, which are not only imperfect, but invasive and expensive to collect,” said senior author Rob Knight, PhD, professor in the Departments of Pediatrics at UC San Diego School of Medicine and Computer Science and Engineering and director of the Center for Microbiome Innovation at UC San Diego.

According to Knight, most people with IBD have similar changes in the types of microbes living in their intestinal tracts, relative to healthy people. Yet it’s still difficult to discern healthy people from those with IBD just by looking at the microbes in their fecal samples. In addition, Knight said it’s not yet clear whether the microbial patterns associated with IBD contribute to the disease’s cause or are a result of the disease.

In a separate line of study, pets appear to be a conduit for microbe sharing in a house. Knight and collaborators previously found that microbial communities on adult skin are on average more similar to those of their own dogs than to other dogs. With a fair amount of precision, they can pick your dog out of a crowd based solely on overlap in your microbiomes.

In this latest study, Knight and team collected fecal samples from 85 healthy dogs and 65 dogs with chronic signs of gastrointestinal disease and inflammatory changes confirmed by pathology. To determine which microbial species were living in each sample, they used a technique Knight and collaborators popularized, called 16S rRNA sequencing, to quickly identify millions of bacterial species living in a mixed sample, based on the unique genes they harbor.

With this information, the researchers were able to look for similarities and differences in the microbial species found in IBD and non-IBD dogs. The differences were significant enough that they could distinguish IBD dog feces from non-IBD with more than 90 percent accuracy.

The researchers also compared the dog data to 2014 parallel findings in humans. The team found some similarities in the microbial interactions of IBD samples between dogs and humans, however the overlap was only partial. For example, Fusobacterium bacteria are associated with diseases in humans, but in dogs was associated with the non-IBD samples.

The study’s first author, Yoshiki Vázquez-Baeza, a graduate student in UC San Diego Jacobs School of Engineering’s Department of Computer Science and Engineering and a member of Knight’s lab, noted a potential limitation of the study — there were fewer healthy human samples than IBD samples in the 2014 human data set. But to best of their knowledge, he said, their statistical methods should not be affected by that.

“One of the really nice things about this study is that all of the statistical software packages we used to analyze data are available online, and anyone can see our exact calculations,” said Vázquez-Baeza. “Too often we read about a study with interesting conclusions, but it’s not completely clear how the authors got there. This approach is more open and transparent.”

This approach to diagnosing IBD in dogs is not yet available to veterinarians or dog owners, Vázquez-Baeza said. Moving forward, the researchers would like to study the overlap in IBD and non-IBD gut microbiomes among a series of animals. Zoo animals, for example, experience IBD more often than their wild counterparts, and studying them might help Knight, Vázquez-Baeza and team find key microbial players in IBD across species.

IBD is a family of diseases that includes ulcerative colitis and Crohn’s disease. IBD is characterized by chronic inflammation in the digestive tract, which can cause pain, severe diarrhea and weight loss. IBD can be debilitating and sometimes leads to life-threatening complications. The Centers for Disease Control and Prevention (CDC) estimate that more than 1 million Americans are living with IBD.

Source:  University of California San Diego media release